title: F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
abstract: OBJECTIVE
  To evaluate positron emission tomography (PET) with fluorine-18-labeled fluorodeoxyglucose (FDG) for detection of pancreatic cancer compared with computed tomography (CT) and ultrasonography (US).
  
  
  METHODS
  Forty patients with suspected pancreatic cancer underwent static PET after intravenous injection of 150-300 MBq FDG. Focal FDG accumulation was regarded as a sign of malignancy and was quantitated by calculating differential uptake ratios (DURs) and tumor-liver ratios (TLRs).
  
  
  RESULTS
  Malignancy was histologically proved in 27 patients. PET helped correctly classify 25 of 27 malignant conditions and 11 of 13 benign disorders. DUR and TLR were statistically significantly higher in malignant compared with benign disease (P < .01). False-negative findings were obtained in patients with insulin-dependent diabetes. False-positive findings were noted in a patient with retroperitoneal fibrosis and in one with pancreas divisum with chronic pancreatitis. PET was superior to CT and US in detection of lymph node metastases (13 of 17 vs three of 17 or one of 15, respectively.
  
  
  CONCLUSIONS
  FDG PET has the potential to improve the detection of lymphadenopathy and the differential diagnosis of pancreatic masses.
authors.affiliation: Department of Nuclear Medicine, Technical University of Aachen, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Bares
authors.forename: P
authors.initials: P
authors.lastname: Klever
authors.forename: S
authors.initials: S
authors.lastname: Hauptmann
authors.forename: D
authors.initials: D
authors.lastname: Hellwig
authors.forename: J
authors.initials: J
authors.lastname: Fass
authors.forename: U
authors.initials: U
authors.lastname: Cremerius
authors.forename: V
authors.initials: V
authors.lastname: Schumpelick
authors.forename: C
authors.initials: C
authors.lastname: Mittermayer
authors.forename: U
authors.initials: U
authors.lastname: Büll
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000378:metabolism; D018281:Cholangiocarcinoma / Q000000981:diagnostic imaging / Q000378:metabolism; D003287:Contrast Media; D003847:Deoxyglucose / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D010179:Pancreas / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism; D010195:Pancreatitis / Q000000981:diagnostic imaging; D011237:Predictive Value of Tests; D012372:ROC Curve; D012185:Retroperitoneal Fibrosis / Q000000981:diagnostic imaging; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
chemical_list: D003287:Contrast Media; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose